Abstract: A vehicle system includes a vehicle body defining a vehicle interior and a vehicle exterior, one or more detection devices, a sanitization device, and a controller, the controller including a processor and a non-transitory computer readable and executable instruction set, which when executed, causes the processor to receive data from the one or more detection devices, determine a surface at least one of within the vehicle interior or on the vehicle exterior contacted by a user based at least in part on the data from the one or more detection devices, determine whether the user is within the vehicle based at least in part on the data from the one or more detection devices, and direct the sanitization device to sanitize the surface based at least in part on the data from the one or more detection devices.

Abstract: A vehicle system includes a vehicle body defining a vehicle interior and a vehicle exterior, one or more detection devices including at least one of a microphone and a camera structurally configured to receive data indicative of conditions within the vehicle interior or on the vehicle exterior, a sanitization device, and a controller communicatively coupled to the one or more detection devices and the sanitization device, the controller including a processor and a non-transitory computer readable and executable instruction set, which when executed, causes the processor to receives data from the one or more detection devices, determine a surface at least one of within the vehicle interior or on the vehicle exterior contacted by a user based at least in part on the data from the one or more detection devices, and direct the sanitization device to sanitize the surface.

Abstract: A system for soliciting at least one bid from Mobility as a Service provider systems includes one or more processors and a memory in communication with the one or more processors that stores a front end module and a back end module. The front end module includes instructions that cause the one or more processors to receive trip request information for a trip from a passenger via a user interface of a device. The back end module includes instructions that cause the one or more processors to receive a bid from one of the MaaS provider systems in response to the trip request information and transmit the bid to the MaaS provider systems that did not provide the bid. The bid may include a price for providing transportation services for the passenger based on the trip request information.

Abstract: A gateway may allow for a cloud-based application to connect to a hierarchical type database. The gateway may identify a connection route between a cloud instance and the hierarchical type database. The gateway may translate a SQL call from the cloud-based application to a DL/I call to access data on the hierarchical type database.

Abstract: A gateway may allow for a cloud-based application to connect to a hierarchical type database. The gateway may identify a connection route between a cloud instance and the hierarchical type database. The gateway may translate a SQL call from the cloud-based application to a DL/I call to access data on the hierarchical type database.

Abstract: Functional testing of application software through exercising graphical user interface functions of the application software is automated and enhanced by providing one or more test data sets, one or more classes of panels in which each panel is described according to a set of graphical user interface objects and a set of corresponding methods, and one or more engines which encapsulate one or more test method calls or invocations. During testing and in cooperation with a functional test system, the test data sets are parsed to obtain individual test operations, which are then acting upon by invoking one or more of the engines in order to subject the application program to one or more test conditions. Results are logged, summarized, and optionally emailed to test personnel.

Abstract: Methods for treatment of a subject with therapeutic or diagnostic agents by delivery of the therapeutic or diagnostic agents to the subject via sublytic amounts of terminal complement membrane attack acomplex (MAC) transmembrane channels are described. Also described are methods for delivery of therapeutic or diagnostic agents to cells in vitro via sublytic amounts of MAC transmembrane channels. Pharmaceutical preparations containing MAC transmembrane channel forming agents and kits for the formation of sublytic amounts of MAC transmembrane channels also are provided.